Anti-tumor necrotic factor antibody for treatment of neuro-Behçet's disease, a case report.
A
A
Borhani Haghighi
A
A
Safari
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000473:pathology / Q000628:therapy*; D001921:Brain / Q000473:pathology; D006801:Humans; D007167:Immunotherapy; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008775:Methylprednisolone